<!--HTML document created with Certent Disclosure Management 6.8.4.2-->
<!--Created on: 8/9/2017 2:01:47 PM-->
<html>
	<head>
		<title>
			2017 Q217 Form 8-K Financial Results
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 18pt">
			<a name="_GoBack"></a><font style="display: inline;font-weight:bold;font-size:18pt;">UNITED STATES</font><br /><font style="display: inline;font-size:18pt;"></font><font style="display: inline;font-weight:bold;font-size:18pt;">SECURITIES AND EXCHANGE COMMISSION</font><br /><font style="display: inline;">Washington, D.C. 20549 </font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
			<font style="display: inline;font-size:9pt;">___________________________________________</font>
		</p>
		<p style="margin:8pt 0pt 4pt;text-align:center;font-family:Times New Roman;font-size: 18pt">
			<font style="display: inline;font-weight:bold;font-size:18pt;">FORM 8-K </font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
			<font style="display: inline;font-size:9pt;">__________________________________________</font>
		</p>
		<p style="margin:5pt 0pt 0pt;text-align:center;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">CURRENT REPORT </font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:center;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">Pursuant to Section 13 or 15(d) of the</font><br /><font style="display: inline;font-weight:bold;">Securities Exchange Act of 1934. </font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">Date of Report:&nbsp; </font><font style="display: inline;font-weight:bold;">August 9</font><font style="display: inline;font-weight:bold;">,</font><font style="display: inline;font-weight:bold;"> 201</font><font style="display: inline;font-weight:bold;">7</font><br /><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">(Date of earliest event reported)</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
			<font style="display: inline;font-size:9pt;">___________________________________________</font>
		</p>
		<p style="margin:10pt 0pt 6pt;text-align:center;font-family:Times New Roman;font-size: 22pt">
			<font style="display: inline;font-weight:bold;font-size:22pt;">SciClone Pharmaceuticals, Inc.</font><br /><font style="display: inline;font-size:14pt;"></font><font style="display: inline;font-size:10pt;">(Exact name of registrant as specified in its charter) </font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
			<font style="display: inline;font-size:9pt;">___________________________________________</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:0;margin-left:0pt;">
			<tr style="CellSpacing:0;">
				<td valign="top" style="width:40.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:20.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:40.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr style="CellSpacing:0;">
				<td valign="top" style="width:40.00%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">Delaware</font><br /><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">(State or other jurisdiction </font><br /><font style="display: inline;font-size:10pt;">of incorporation)</font><font style="display: inline;">&nbsp;</font></p>
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:20.00%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">0-19825</font><br /><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">(Commission File Number)</font><font style="display: inline;">&nbsp;</font></p>
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:40.00%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">94-3116852</font><br /><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">(IRS Employer </font><br /><font style="display: inline;font-size:10pt;">Identification Number)</font><font style="display: inline;">&nbsp;</font></p>
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr style="CellSpacing:0;">
				<td valign="middle" style="width:40.00%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">950 Tower Lane, Suite 900, </font><br /><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;">Foster City, CA </font><br /><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">(Address of principal executive offices)</font><font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:20.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:40.00%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">94404</font><br /><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">(Zip Code)</font><font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr style="CellSpacing:0;">
				<td colspan="3" valign="middle" style="width:100.00%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font><br /><font style="display: inline;">(</font><font style="display: inline;font-weight:bold;">650) 358-3456</font><br /><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">(Registrant's telephone number, including area code)</font><font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr style="CellSpacing:0;">
				<td colspan="3" valign="middle" style="width:100.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr style="CellSpacing:0;">
				<td colspan="3" valign="middle" style="width:100.00%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">Not Applicable</font><br /><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">(Former Name or Former Address, if changed since last report)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
			<font style="display: inline;font-size:9pt;">___________________________________________</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
			<font style="display: inline;font-size:9pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#x2610;</font><font style="display: inline;font-size:10pt;"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#x2610;</font><font style="display: inline;font-size:10pt;"> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#x2610;</font><font style="display: inline;font-size:10pt;"> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:10pt;">&#x2610;</font><font style="display: inline;font-size:10pt;"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 8pt">
			<font style="display: inline;font-size:8pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 40</font><font style="display: inline;font-size:10pt;">5 of the Securities Act of 1933 </font><font style="display: inline;font-size:10pt;">(&#xA7;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#xA7;240.12b-2 of this chapter).</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">Emerging growth company</font><font style="display: inline;font-size:10pt;">&nbsp;&nbsp;&nbsp;</font><font style="display: inline;font-size:10pt;">&#x2610;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 8pt">
			<font style="display: inline;font-size:8pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the exte</font><font style="display: inline;font-size:10pt;">nded transition period for </font><font style="display: inline;font-size:10pt;">complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</font><font style="display: inline;font-size:10pt;">&nbsp;&nbsp;&nbsp;</font><font style="display: inline;font-size:10pt;">&#x2610;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;font-size:10pt;"></font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">Item 2.02</font><font style="display: inline;font-weight:bold;font-size:11pt;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style="display: inline;font-weight:bold;font-size:11pt;">Results of Operations and Financial Condition</font><font style="display: inline;font-weight:bold;font-size:11pt;"> &nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:120%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:21.6pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">On </font><font style="display: inline;font-size:11pt;">August</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">9</font><font style="display: inline;font-size:11pt;">, 201</font><font style="display: inline;font-size:11pt;">7</font><font style="display: inline;font-size:11pt;">, SciClone Pharmaceuticals, Inc. issued a press release announcing final financial results for the </font><font style="display: inline;font-size:11pt;">second</font><font style="display: inline;font-size:11pt;"> quarter ended </font><font style="display: inline;font-size:11pt;">June 30</font><font style="display: inline;font-size:11pt;">, 201</font><font style="display: inline;font-size:11pt;">7</font><font style="display: inline;font-size:11pt;">. The press release is attached hereto as </font><font style="display: inline;font-weight:bold;font-size:11pt;text-decoration:underline;">Exhibit 99.1</font><font style="display: inline;font-size:11pt;"> and is incorporated by reference herein in its entirety.</font><font style="display: inline;font-size:11pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:21.6pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">The </font><font style="display: inline;font-size:11pt;">information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 to this Current Report on Form 8-K, shall not be deemed to be &#x201C;filed&#x201D; for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the &#x201C;Exchange Act&#x201D;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:120%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style="display: inline;font-weight:bold;font-size:11pt;">Financial Statements and Exhibits</font>
		</p>
		<p style="margin:0pt;line-height:120%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:120%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">(d) </font><font style="display: inline;font-size:11pt;">The following exhibits are filed herewith:</font>
		</p>
		<p style="margin:0pt;line-height:120%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:414.90pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:67.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:347.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:67.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Exhibit 99.1</font></p>
				</td>
				<td valign="top" style="width:347.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Press release dated </font><font style="display: inline;font-size:11pt;">August 9</font><font style="display: inline;font-size:11pt;">, 201</font><font style="display: inline;font-size:11pt;">7</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:120%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-weight:bold;font-size:11pt;">SIGNATURE</font>
		</p>
		<p style="margin:5pt 0pt;text-indent:21.6pt;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </font>
		</p>
		<p style="margin:5pt 0pt;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:30.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:05.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:63.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:30.72%;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Dated: </font><font style="display: inline;font-size:11pt;">August 9</font><font style="display: inline;font-size:11pt;">, 201</font><font style="display: inline;font-size:11pt;">7</font></p>
				</td>
				<td colspan="2" valign="top" style="width:69.28%;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">SCICLONE PHARMACEUTICALS, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:30.72%;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:05.58%;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:63.70%;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:30.72%;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:05.58%;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">By:</font></p>
				</td>
				<td valign="top" style="width:63.70%;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;font-family:Times New Roman;font-size: 11pt">
						<font style="text-indent:0pt;margin-left:0pt; padding-right:179.6pt;"><font style="display: inline;font-size:11pt;">/s/ </font><font style="display: inline;font-size:11pt;">Wilson W. Cheung</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:right"><font style="display: inline;font-size:11pt;"></font></font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:30.72%;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:05.58%;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:63.70%;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Wilson W. Cheung</font><font style="display: inline;font-size:11pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:30.72%;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:05.58%;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:63.70%;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Chief Financial Officer and </font></p>
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Senior Vice President, Finance</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:5pt 0pt 0pt;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-weight:bold;font-size:11pt;text-decoration:underline;">Exhibit Index</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;text-decoration:underline;">Exhibit No.</font><font style="display: inline;font-size:11pt;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style="display: inline;font-weight:bold;font-size:11pt;text-decoration:underline;">Description</font>
		</p>
		<p style="margin:5pt 0pt 0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style="display: inline;font-size:11pt;">Press release dated </font><font style="display: inline;font-size:11pt;">August 9</font><font style="display: inline;font-size:11pt;">,</font><font style="display: inline;font-size:11pt;"> 201</font><font style="display: inline;font-size:11pt;">7</font><font style="display: inline;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:5pt 0pt 0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "scln-20170809x8k.htm", "description": "8-K", "secsgml_size_bytes": 28250}]
{"company-data": {"conformed-name": "SCICLONE PHARMACEUTICALS INC", "cik": "0000880771", "assigned-sic": "2834", "irs-number": "943116852", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-19825", "film-number": "171017977"}, "business-address": {"street1": "950 TOWER LANE", "street2": "SUITE 900", "city": "FOSTER CITY", "state": "CA", "zip": "94404-2125", "phone": "650-358-3456"}, "mail-address": {"street1": "950 TOWER LANE", "street2": "SUITE 900", "city": "FOSTER CITY", "state": "CA", "zip": "94404-2125"}}
2017 Q217 Form 8-K Financial Results
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________
FORM 8-K
__________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934.
Date of Report:
August 9
,
201
7
(Date of earliest event reported)
___________________________________________
SciClone Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
___________________________________________
﻿
﻿
Delaware
(State or other jurisdiction
of incorporation)
0-19825
(Commission File Number)
94-3116852
(IRS Employer
Identification Number)
950 Tower Lane, Suite 900,
Foster City, CA
(Address of principal executive offices)
94404
(Zip Code)
(
650) 358-3456
(Registrant's telephone number, including area code)
Not Applicable
(Former Name or Former Address, if changed since last report)
___________________________________________
﻿
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
﻿
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 40
5 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
﻿
If an emerging growth company, indicate by check mark if the registrant has elected not to use the exte
nded transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 2.02
Results of Operations and Financial Condition
﻿
On
August
9
, 201
7
, SciClone Pharmaceuticals, Inc. issued a press release announcing final financial results for the
second
quarter ended
June 30
, 201
7
. The press release is attached hereto as
Exhibit 99.1
and is incorporated by reference herein in its entirety.
﻿
The
information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 to this Current Report on Form 8-K, shall not be deemed to be "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
﻿
﻿
Item 9.01
Financial Statements and Exhibits
(d)
The following exhibits are filed herewith:
﻿
﻿
Exhibit 99.1
Press release dated
August 9
, 201
7
﻿
﻿
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
﻿
﻿
Dated:
August 9
, 201
7
SCICLONE PHARMACEUTICALS, INC.
﻿
﻿
By:
/s/
Wilson W. Cheung
﻿
Wilson W. Cheung
﻿
Chief Financial Officer and
Senior Vice President, Finance
﻿
﻿
Exhibit Index
﻿
﻿
Exhibit No.
Description
99.1
Press release dated
August 9
,
201
7
.
﻿
﻿